Paragon Care's (ASX:PGC) acquisition of healthcare distributor Somnotec will be accretive to earnings per share by around 2% to 3% in fiscal 2026 and 7% in 2027, Euroz Hartleys said in a note on Tuesday.
The medical devices supplier bought Singapore-based Somnotec for an enterprise value of about A$28.4 million.
The deal is projected to accelerate Paragon Care's expansion in Asia and boost its ability to cater to original equipment manufacturers in the region.
Euroz Hartleys kept its buy rating and raised price target to AU$0.61 from AU$0.60.